IP Library › Assignment 025084/0169
Patent Assignment
Reel/Frame 025084/0169

Security Agreement

Recorded: 2010-10-04 Received: 2010-10-04 Pages: 29
Assignors
ATON PHARMA, INC.
Executed: 2010-09-27
CORIA LABORATORIES, LTD.
Executed: 2010-09-27
DOW PHARMACEUTICAL SCIENCES, INC.
Executed: 2010-09-27
Assignee
GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
200 WEST STREET, NEW YORK, NY, 10282, UNITED STATES
Covered Properties (80)
Azithromycin for the treatment of nodular acne
Application: 12/799,401 →
N-(4-(6-Fluoro-3,4-Dihydroisoquinolin-2(1H)-Yl)-2,6-Dimethylphenyl)-3,3-Dimethylbutanamide as Potassium Channel Modulators
Application: 12/698,070 →
Modified Release Formulation and Methods of Use
Application: 12/691,680 →
Modified Release Formulation and Methods of Use
Application: 12/690,889 →
Stereoselective Synthesis of Metyrosine
Application: 61/256,926 →
Ocular Drug Delivery Devices
Application: 61/256,915 →
Aqueous compositions containing metronidazole
Application: 12/589,680 →
Method for obtaining a stable dispersion of benzoyl peroxide
Application: 12/589,236 →
Modified Release Formulation and Methods of Use
Application: 12/505,409 →
Benzyloxy Anilide Derivatives Useful as Potassium Channel Modulators
Application: 12/491,055 →
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Application: 12/455,525 →
Imiquimod formulation
Application: 12/319,978 →
Silicone Gel-Based Compositions for Wound Healing and Scar Reduction
Application: 12/242,681 →
Azithromycin for Treatment of Skin Disorders
Application: 12/231,586 →
Derivatives of 5-Amino-4,6-Disubstituted Indole and 5-Amino-4,6-Disubstituted Indoline as Potassium Channel Modulators
Application: 12/189,709 →
Naphthyridine Derivatives as Potassium Channel Modulators
Application: 12/181,126 →
Uses of Trientine and Penicillamine as Countermeasures to Metal Contamination
Application: 12/180,130 →
Modified Release Formulation and Methods of Use
Application: 61/082,162 →
Benzyloxy Anilide Derivatives Useful as Potassium Channel Modulators
Application: 61/075,307 →
3-Hydroxyisothiazole-4-Carboxamidine Derivatives as CHK2 Inhibitors
Application: 12/143,672 →
Derivatives of 4-(N-Azacycloalkyl) Anilides as Potassium Channel Modulators
Application: 12/138,251 →
Method for increasing the solubility of betacyclodextrin
Application: 12/072,578 →
Method for Stabilizing Polypeptides Lacking Methionine
Application: 12/069,745 →
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Application: 12/012,413 →
Drug Delivery System for Administering an Adjustable Preset Dose
Application: 12/014,739 →
Compositions and methods for treating diseases of the nail
Application: 12/006,531 →
Controlled Release Azithromycin Solid Dosages Forms
Application: 12/002,417 →
1,4 Diamino Bicyclic Retigabine Analogues as Potassium Channel Modulators
Application: 11/946,822 →
N-[2-Amino-4-(Phenylmethoxy)Phenyl] Amides and Related Compounds as Potassium Channel Modulators
Application: 11/870,368 →
Silicone gel-based compositions for wound healing and scar reduction
Application: 60/997,166 →
Azithromycin for treatment of skin disorders
Application: 60/967,504 →
Derivatives of 4-(N-Azacycloalkyl) Anilides as Potassium Channel Modulators
Application: 11/894,877 →
Derivatives of 1,3-diamino benzene as potassium channel modulators
Application: 11/893,724 →
Derivatives of 5-amino-4 6-disubstituted indole and 5-amino-4 6-disubstituted indoline as potassium channel modulators
Application: 60/964,526 →
Naphthyridine derivatives as potassium channel modulators
Application: 60/962,862 →
Topical Acne Vulgaris Medication with a Sunscreen
Application: 11/823,385 →
3-Hydroxyisothiazole-4-carboxamidine derivatives as Chk2 inhibitors
Application: 60/936,720 →
Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
Application: 60/934,396 →
Substituted Arylamino -1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
Application: 11/810,114 →
Silicone based emulsions for topical drug delivery
Application: 11/699,906 →
Two-phase mucoadhesive composition
Application: 11/654,921 →
Azithromycin for the Treatment of Nodular Acne
Application: 11/635,127 →
1,4 Diamino Bicyclic Retigabine Analogues as Potassium Channel Activators
Application: 60/867,482 →
N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel activators
Application: 60/850,867 →
N-[2-amino-4-(phenylmethoxy)phenyl]carbamic acid esters and related compounds as potassium channel activators
Application: 60/851,084 →
Azithromycin for the treatment of nodular acne
Application: 60/849,065 →
Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel activators
Application: 60/839,941 →
Derivatives of 3-(N-azacycloalkyl) anilides as potassium channel activators
Application: 60/839,642 →
Derivatives of 1,3-diamino benzene as potassium channel activators
Application: 60/838,808 →
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
Application: 60/833,886 →
Alpha Hydroxy Acid Sustained Release Formulation
Application: 11/490,896 →
Substituted arylamino -1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1H-indenes as KCNQ activators
Application: 60/811,463 →
Use of a clobetasol spray formulation to treat psoriasis
Application: 11/408,105 →
Topical Acne Vulgairs Medication with a Sunscreen
Application: 11/393,981 →
2-Beta-Modified-6-Substituted Adenosine Analogs and Their Use as Antiviral Agents
Application: 10/530,627 →
Novel Heterocyclic Compounds Having Anti-Hbv Activity
Application: 11/347,145 →
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
Application: 10/542,235 →
Container
Application: 29/243,316 →
Single-enantiomer n-(4-bromo-or-3-tri-fluoromethyl)phenyl-thiazolidinones, oxazolidinones and pyrrolidinones for HBV
Application: 60/706,602 →
Single-enantiomer thiazolidinones, oxazolidinones, and pyrrolidinones for HBV
Application: 60/701,819 →
3', 5'-Cyclic nucleotide analogs for treatment of HCV infection
Application: 60/681,332 →
Phosphoramidate prodrugs of 2'-methyl ribonucleotides
Application: 60/678,636 →
Aqueous Compositions Containing Metronidazole
Application: 11/037,430 →
Candy Container
Application: 29/204,929 →
Container for Semi-Liquid Candy
Application: 29/203,869 →
Quinoxaline Derivatives Having Antiviral Activity
Application: 10/826,439 →
Combinations of Retigabine and Sodium Channel Inhibitors or Sodium Channel-Influencing Active Compounds for Treating Pains
Application: 10/727,655 →
Container for Semi-Liquid Candy
Application: 29/193,453 →
Container for Semi-Liquid Candy
Application: 29/193,454 →
Container for Liquid Candy
Application: 29/191,159 →
Heterocyclic Compounds and Uses Thereof
Application: 10/455,149 →
Antiviral Phosphonate Compounds and Methods Therefor
Application: 10/426,507 →
Drug Delivery System for Administering an Adjustable Preset Dose
Application: 10/367,626 →
Nucleoside Compounds and Uses Thereof
Application: 10/318,476 →
Nucleoside Analogs with Carboxamidine Modified Monocyclic Base
Application: 10/227,235 →
Tirazole Nucleoside Analogs and Methods for Using Same
Application: 10/095,665 →
Skin Cream
Application: 10/094,534 →
Topical Gel Delivery System
Application: 10/096,516 →
Aqueous Compositions Containing Metronidazole
Application: 10/033,835 →
Skin Cleanser Comprising a Steareth, Poloxamer and a Glyceryl Monoester
Application: 09/802,047 →